TACE Plus Lenvatinib and Tislelizumab for Intermediate-Stage Hepatocellular Carcinoma Beyond Up-to-11 Criteria: a Multicenter Cohort Study
FRONTIERS IN IMMUNOLOGY（2024）
关键词
hepatocellular carcinoma,intermediate-stage,up-to-eleven criteria,transartrial chemoembolization,combination therapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要